Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
New Oxford Neurodevelopment Consortium

New Oxford Neurodevelopment Consortium

Research Clinical Neurology

Professor Andrea Németh has successfully applied to the John Fell Fund to establish the Oxford Neurodevelopment Consortium (OxNDC).

New drug trial for Parkinson's

New drug trial for Parkinson's

Research Clinical Neurology

Our researchers have been granted 600K euros from EU’s Horizon 2020 Framework Programme to join in a multi-centre initiative studying a new drug for Parkinson's disease

New Wellcome Trust Centre for Integrative Neuroimaging

New Wellcome Trust Centre for Integrative Neuroimaging

Integrative Neuroimaging

The Wellcome Trust has today announced five-year funding for 14 major research centres, including a centre for neuroimaging in Oxford

Oxford scientists involved in world’s biggest body scanning project

Oxford scientists involved in world’s biggest body scanning project

Integrative Neuroimaging

The world’s largest health imaging study, funded by the Medical Research Council, Wellcome Trust, and the British Heart Foundation is launched today. It will create the biggest collection of scans of internal organs, and transform the way scientists study a wide range of diseases.

£23 million boost for Oxford spinout company

£23 million boost for Oxford spinout company

Ophthalmology

More money comes in to further work on gene therapy for choroideremia

New Fellow to develop treatment for retinal disorder

New Fellow to develop treatment for retinal disorder

Ophthalmology

Harry Orlans will work with Robert MacLaren to develop a treatment for retinitis pigmentosa.

New £1.3m research consortium for spinal muscular atrophy

New £1.3m research consortium for spinal muscular atrophy

Clinical Neurology Research

Researchers in our Department will lead a new collaborative initiative for Spinal Muscular Atrophy (SMA) research in the UK over the next three years. The programme is funded by the SMA Trust.

New system to identify patients at risk of admission to intensive care

New system to identify patients at risk of admission to intensive care

Anaesthetics

Researchers and clinicians from Oxford and Portsmouth have been awarded £1.8m by the Health Innovation Challenge Fund to develop a new electronic system to recognise deteriorating patients in hospitals.

Two major grants for Oxford's Parkinson's research

Two major grants for Oxford's Parkinson's research

Clinical Neurology

Oxford receives major funding to work on Parkinson’s, a neurological condition which can leave people struggling to walk, speak and sleep.

New tool being developed to fight motor neuron disease

New tool being developed to fight motor neuron disease

Innovate UK has awarded an Oxford-based consortium £850k to validate epigenetic signatures in patients with the motor neurone disease Amyotrophic Lateral Sclerosis (ALS).

Researchers aim to help patients sleep better during their stay in hospital

Researchers aim to help patients sleep better during their stay in hospital

Anaesthetics

Professor Duncan Young has been awarded £280,000 by the National Institute for Health Research (NIHR) to look at the problem of noise levels and sleep in the intensive care unit.

New research to investigate if neuroscience can improve teaching and learning in schools

New research to investigate if neuroscience can improve teaching and learning in schools

Can physical fitness improve academic achievement? Would teenagers do better in their exams if they could sleep in and start school later? These questions will be part of a multi-million pound research project, funded by the Wellcome Trust and the Education Endowment Foundation (EEF), to investigate a variety of ways neuroscience might improve teaching and learning in the UK.

Stem cells for Biological Assays of Novel drugs and predictive toxiCology (StemBANCC)

Stem cells for Biological Assays of Novel drugs and predictive toxiCology (StemBANCC)

Research Clinical Neurology

Oxford University has recently led a successful bid to establish a €52M international consortium to develop induced pluripotent stem (iPS) cell lines for drug discovery and safety assessment.